Sonata Capital Group Inc Pfizer Inc Transaction History

Sonata Capital Group Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$41.75 - $54.5 $184,117 - $240,345	4,410 New	4,410 $226,000
Q1 2022 Apr 22, 2022	SELL	$45.75 - $56.69 $34,678 - $42,971	-758 Reduced 15.57%	4,110 $213,000
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $31,320 - $46,427	-758 Reduced 13.47%	4,868 $287,000
Q3 2021 Nov 08, 2021	SELL	$39.25 - $50.42 $72,180 - $92,722	-1,839 Reduced 24.63%	5,626 $242,000
Q1 2021 May 03, 2021	SELL	$33.49 - $37.77 $107,569 - $121,317	-3,212 Reduced 30.08%	7,465 $270,000
Q4 2020 Jan 29, 2021	BUY	$33.47 - $42.56 $13,388 - $17,024	400 Added 3.89%	10,677 $393,000
Q2 2020 Aug 03, 2020	SELL	$30.12 - $36.54 $109,215 - $132,494	-3,626 Reduced 26.08%	10,277 $336,000
Q1 2020 Apr 27, 2020	SELL	$27.03 - $38.62 $62,169 - $88,826	-2,300 Reduced 14.19%	13,903 $454,000
Q4 2019 Jan 30, 2020	BUY	$32.92 - $37.36 $9,876 - $11,208	300 Added 1.89%	16,203 $635,000
Q2 2019 Aug 05, 2019	SELL	$36.98 - $41.52 $24,110 - $27,071	-652 Reduced 3.94%	15,903 $689,000
Q1 2019 Apr 23, 2019	SELL	$37.5 - $41.2 $37,500 - $41,200	-1,000 Reduced 5.7%	16,555 $703,000
Q3 2018 Oct 31, 2018	BUY	$34.47 - $41.81 $8,445 - $10,243	245 Added 1.42%	17,555 $774,000
Q2 2018 Aug 01, 2018	SELL	$32.98 - $35.16 $38,388 - $40,926	-1,164 Reduced 6.3%	17,310 $628,000
Q1 2018 Apr 25, 2018	BUY	$31.91 - $37.02 $1,595 - $1,851	50 Added 0.27%	18,474 $656,000
Q4 2017 Jan 29, 2018	SELL	$33.26 - $35.29 $71,775 - $76,155	-2,158 Reduced 10.48%	18,424 $667,000
Q3 2017 Nov 02, 2017	BUY	$31.0 - $34.15 $638,042 - $702,875	20,582	20,582 $735,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Sonata Capital Group Inc, based on Form 13F filings with the SEC.

Stay updated on Sonata Capital Group Inc with notifications on news.